Daniel Avery
MSc
Data Analyst
Daniel Avery is a Data Analyst with the China Kadoorie Biobank at the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU), University of Oxford.
He graduated with an MSc in Research Methods from the University of Bristol before working for a number of companies in the retail sector performing data management roles. He is responsible for helping develop and manage the CKB database, ensuring the research team and collaborators have access to reliable and high quality data.
His primary duties include:
Developing and maintaining several of the tools used for automatic generation of datasets, as well as tools used for building and testing new data releases.
Acting as a knowledge bank for in-house researchers, about how data was gathered and managed, as well as known pitfalls or challenges associated with each data source.
Importing, cleaning and standardising information from sources as diverse as Health Insurance agencies, meteorological stations, urinalysis devices and genetic assays.
Recent publications
Diagnostic accuracy, treatment and prognosis of myocardial infarction: an 11-year follow-up of a community-based cohort of 0.5 million Chinese adults
Journal article
CHEN Z. et al, (2026), BMJ Public Health
Dairy consumption and risk of cardiometabolic diseases: a prospective cohort study of the China Kadoorie Biobank.
Journal article
Kakkoura MG. et al, (2026), J Nutr
ssociations of 2923 Olink proteins with demographic, lifestyle, environmental and health characteristics in middle-aged Chinese adults.
Journal article
Iona A. et al, (2025), Eur J Epidemiol, 40, 1205 - 1220
Proteome-Wide Genetic Study in East Asians and Europeans Identified Multiple Therapeutic Targets for Ischemic Stroke.
Journal article
Yao P. et al, (2025), Stroke, 56, 2147 - 2158
Causal Relevance of Lp(a) for Coronary Heart Disease and Stroke Types in East Asian and European Ancestry Populations: A Mendelian Randomization Study.
Journal article
Clarke R. et al, (2025), Circulation, 151, 1699 - 1711
